The European Union (EU) launched a €32 million Special Measure on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+) to support the development of vaccine manufacturing and the pharmaceutical industry in Ghana.
This significant investment, launched during the Ghana-EU Business Forum, aims to strengthen Ghana’s healthcare sector and increase access to quality health products.
Through this initiative, the EU will support Ghana in establishing a thriving ecosystem able to produce the needed skilled workforce, strengthen research and development capacities, establish the necessary regulatory system (continuing to support the Food and Drugs and Authority), facilitate technology transfer and build bilateral and multilateral partnerships for vaccine and pharmaceutical production.
The EU’s support to local vaccine manufacturing in Ghana through MAV+ comes on top of the planned Joint Programming for 2021-2027, which shows the EU’s ability to adapt to rapidly emerging needs and trends, and its strong commitment to support and respond to high political priorities of the Government of Ghana.
The Deputy Director General, Directorate General of the European Commission, Myriam Ferran, said, “The European Union is committed to supporting Ghana's development goals, and this investment in vaccine manufacturing and pharma is a testament to our partnership; this programme will not only enhance Ghana's healthcare sector but also contribute to the growth of the country's economy."
![](https://www.myjoyonline.com/wp-content/uploads/2024/07/image-237-1024x683.png)
Presidential Advisor on Health, Dr Anthony Nsiah-Asare, said, “We are working together with the
EU from the beginning of the President’s vision to make Ghana become a regional vaccine
manufacturing hub. A say a big thank you to EU for the incredible close collaboration.”
Since 2022, the EU has already started delivering on its promises, giving support to vaccine
manufacturing both at the private and public levels in Ghana.
Together with the German Development Cooperation, the EU launched a €3.1 million project aimed at enhancing the capacity of Ghana’s Food and Drugs Authority.
This forms a crucial initiative to ensure that vaccines made in the country fulfil the quality standards to gain access to regional and global markets.
On the other hand, in 2023, through the European Investment Bank, the EU provided a €5 million
grant to DEK Vaccines Ltd, providing seed financing to support the construction of a fill-and-finish
vaccine manufacturing facility located at Medie in the Greater Accra region.
Latest Stories
-
35th CIMG Awards: Full list of winners
1 hour -
The Multimedia Group wins big at CIMG Awards 2023
2 hours -
Bernard Mornah wins PNC flagbearship race
2 hours -
Video: Confusion at PNC National Executives election
3 hours -
Rapper E.L. joins King Promise as Guinness Accravaganza headliner for September 21 showdown
4 hours -
PNC Congress: Bernard Mornah leads in Greater Accra Region
4 hours -
Reject violence, divisive rhetoric, embrace peace ahead of elections – Bawumia appeals to Ghanaians
5 hours -
SEFF’s debut single ‘Father’ sets stage for bold new talent
6 hours -
Super typhoon Yagi kills four in Vietnam
6 hours -
Hollard Insurance-UENR Mentoring Day: Students urged to let hard work, integrity shine to advance career
6 hours -
2024/25 GPL: Vision FC opens campaign with draw against Berekum Chelsea
6 hours -
If Baba Yara pitch was good, Mumin clears the ball – Laryea Kingston
7 hours -
GPL 2024/25: Samartex begin title defence with draw against Dreams FC
7 hours -
Financing road construction and maintenance through a special fuel levy: A sustainable solution for Ghana’s road infrastructure
7 hours -
Ghana Celebrity Impact Awards 2024 launched to honor positive social influence
8 hours